EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Angiotensin II Type-1 Receptor Antibody in Solid Organ Transplantation – Is It Time to Test?

Paul James Patrick Martin, Michelle Willicombe, Candice Roufosse

Transplant International · 13.11.2024 · 37

DOI: 10.3389/ti.2024.13280 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Transplant International, online erschienen am 13.11.2024. Verfasst von Paul James Patrick Martin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Inflammation, Imperial College London, Hammersmith Campus, London, United Kingdom. Hauptthemen laut MEDLINE: Receptor, Angiotensin, Type 1, Graft Rejection, Organ Transplantation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Angiotensin II type-1 receptor antibody (AT1R-Ab) has been mooted as a potential effector of both acute and chronic antibody mediated rejection (AMR). A growing body of literature on the topic is now coming under scrutiny in the context of the evolving Banff AMR diagnostic classification system and refinement of recommendations for histocompatibility testing by the Sensitization in Transplantation Assessment of Risk (STAR) workgroup. This mini-review discusses the latest understanding of pathophysiological mechanisms, clinical evidence for the pathogenicity of AT1R-Ab, and methods of laboratory testing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Angiotensin, Type 1Graft RejectionOrgan TransplantationHumansKidney TransplantationHistocompatibility Testing

Stichwörter der Autor:innen

AT1RAT1R antibodyantibody mediated rejectionnon-HLA antibodyrejection

Substanzen

Receptor, Angiotensin, Type 1

Autor:innen und Institutionen

  • Department of Immunology and Inflammation, Imperial College London, Hammersmith Campus, London, United Kingdom.
  • Imperial College Renal and Transplant Centre, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom.
  • Department of Histopathology, Northwest London Pathology NHS Trust, Charing Cross Hospital, London, United Kingdom.

Zitieren

APA

Martin, P. J. P., Willicombe, M., & Roufosse, C. (2024). Angiotensin II Type-1 Receptor Antibody in Solid Organ Transplantation – Is It Time to Test?. Transplant International, 37. https://doi.org/10.3389/ti.2024.13280

Vancouver

Martin PJP, Willicombe M, Roufosse C. Angiotensin II Type-1 Receptor Antibody in Solid Organ Transplantation – Is It Time to Test?. Transplant International. 2024;37. doi:10.3389/ti.2024.13280

BibTeX
@article{Martin2024,
  author = {Martin, Paul James Patrick and Willicombe, Michelle and Roufosse, Candice},
  title = {Angiotensin II Type-1 Receptor Antibody in Solid Organ Transplantation – Is It Time to Test?},
  journal = {Transplant International},
  year = {2024},
  volume = {37},
  doi = {10.3389/ti.2024.13280}
}
Kostenlos starten →